Conformation-specific monoclonal antibodies reveal early Tau structural intermediates in Alzheimer’s disease Tauopathy, including Alzheimer’s disease, is the most prevalent neurodegenerative disorder, yet current therapies fail to halt disease progression, partly because of limited understanding of early tau...

Early-stage Tau folding may be the trigger for Alzheimer's aggregation. A new study tracks structural changes before fibrils even form. rPeptide's Tau-441 (Cat# T-1001) supported the research 🧬🧠

t.ly/60OGC

#Alzheimers #Neuroscience #TauProtein #Tauopathy #rPeptide

Tau Preformed Fibrils Archives

Looking for Tau Protein Fibrils for your research needs? rPeptide has got you covered, we offer Tau-441 Preformed Fibrils and FITC Tau-441 PFFs!

t.ly/1My4e

Reach out to Sales@rPeptide.com for a quote or to place an order!

#AlzheimersResearch #TauProtein #Tau441 #TauFibrils #PFFs #FITC #rPeptide

Chemists determine the structure of the fuzzy coat that surrounds Tau proteins MIT chemists showed they can use nuclear magnetic resonance (NMR) to decipher the structure of the fuzzy coat that surrounds Tau proteins. The findings may aid efforts to develop drugs that interfere ...

New from MIT: the "fuzzy coat" around Alzheimer's-linked Tau protein fibrils finally has a structure, and it could change how we think about treating neurodegeneration. 🔍

t.ly/O_X3w

#Alzheimers #Neuroscience #TauProtein #MITResearch #rPeptide

Scientists uncover why some brain cells resist Alzheimer's disease – BioNews Central New research reveals why some brain neurons resist toxic tau protein buildup—a hallmark of Alzheimer’s and related dementias—potentially aiding new therapy targets. ...

New research reveals why some #brain #neurons resist the toxic buildup of #TauProtein—a hallmark of #Alzheimers and related #dementias—potentially aiding the development of #NewTherapies.

With new investor backing, the company prepares a £25m Series A to move its lead tauC3 antibody into human trials.

longevity.technology/news/tauc3-b...

#Neurodegeneration #TauProtein #Biotech #FrontotemporalDementia #BrainTherapy #longevity #TauC3 #Innovation #ClinicalResearch

Incubation with tau aggregates increases hippocampal circuit excitability and enhances long-term depression in acute mouse hippocampal slices Aggregation of the protein tau is a key pathological hallmark of tauopathies such as Alzheimer’s Disease. Tau dissociates from microtubules and diffuses from the axon into the soma-dendritic compartment, where it aggregates firstly into oligomers ...

Tau buildup doesn’t just mark disease—it changes how neurons talk. 🧠

Using rPeptide’s Tau-441 PFFs, researchers found Tau aggregates shift brain signaling toward long-term depression, mirroring early Alzheimer’s disruptions.

t.ly/SmJ7G

#Neuroscience #TauProtein #AlzheimersResearch #rPeptide

Gamma frequency sensory stimulation may benefit some Alzheimer’s disease patients – BioNews Central A small study found that gamma-frequency sensory stimulation was associated with sustained cognitive scores and reduced tau levels in Alzheimer’s disease patients. ...

A small study found that #GammaFrequency #SensoryStimulation was associated with sustained #cognitive scores and reduced #TauProtein levels in #AlzheimersDisease patients.
#AlzheimersTherapy

"... konnte nun die Rolle eines Proteins namens „Tau“ neu definieren, das insbesondere in Nervenzellen an Mikrotubuli bindet. Denn: „Es hilft dabei, dass defekte Abschnitte durch den Einbau neuer Bausteine ersetzt werden können“ ... "
#TauProtein

The Hidden Dangers of Repeated Head Impacts: Understanding CTE and Brain Health

#BrainHealth #CTE #TraumaticBrainInjury #Concussion #Neurodegeneration #TauProtein #Dementia #BrainResearch #Neuroscience #HeadTrauma

youtube.com/shorts/sSpS8...

The Science Behind Chronic Traumatic Encephalopathy (CTE)

#BrainHealth #CTE #Neurodegeneration #TraumaticBrainInjury #TauProtein #NeuroPathology #BrainScience #ConcussionAwareness #Neuroscience #ProtectYourBrain

youtube.com/shorts/9RmP6...

Simulated transport and production dynamics in the local FKPP model. Left: Simulation from the local FKPP model using carrying capacities derived from Gaussian mixture models (shown top right). Each line in the middle panel represents the SUVR trajectory of one DK atlas brain region. Values at time points years are projected onto a cortical rendering in the top panel. Each line in the bottom panel represents concentration averaged over Braak regions. Top right: Two component Gaussian mixture model fit to a multi-cohort tau PET dataset [24] and data from ADNI for right inferior temporal lobe. Bottom right: Right hemisphere cortical rendering of the SUVR carrying capacities as determined through Gaussian mixture modelling.

Accumulation of aggregated tau shows a complex spatio-temporal pattern during #AlzheimersDisease, but why? @pavanchaggar.bsky.social @alaingoriely.bsky.social &co describes #TauProtein dynamics in AD, showing stage-specific shifts in production & transport @plosbiology.org 🧪 plos.io/4kNA6vX

Simulated transport and production dynamics in the local FKPP model. Left: Simulation from the local FKPP model using carrying capacities derived from Gaussian mixture models (shown top right). Each line in the middle panel represents the SUVR trajectory of one DK atlas brain region. Values at time points years are projected onto a cortical rendering in the top panel. Each line in the bottom panel represents concentration averaged over Braak regions. Top right: Two component Gaussian mixture model fit to a multi-cohort tau PET dataset [24] and data from ADNI for right inferior temporal lobe. Bottom right: Right hemisphere cortical rendering of the SUVR carrying capacities as determined through Gaussian mixture modelling.

Accumulation of aggregated tau shows a complex spatio-temporal pattern during #AlzheimersDisease, but why? @pavanchaggar.bsky.social @alaingoriely.bsky.social &co describes #TauProtein dynamics in AD, showing stage-specific shifts in production & transport @plosbiology.org 🧪 plos.io/4kNA6vX

Simulated transport and production dynamics in the local FKPP model. Left: Simulation from the local FKPP model using carrying capacities derived from Gaussian mixture models (shown top right). Each line in the middle panel represents the SUVR trajectory of one DK atlas brain region. Values at time points years are projected onto a cortical rendering in the top panel. Each line in the bottom panel represents concentration averaged over Braak regions. Top right: Two component Gaussian mixture model fit to a multi-cohort tau PET dataset [24] and data from ADNI for right inferior temporal lobe. Bottom right: Right hemisphere cortical rendering of the SUVR carrying capacities as determined through Gaussian mixture modelling.

Accumulation of aggregated tau shows a complex spatio-temporal pattern during #AlzheimersDisease, but why? @pavanchaggar.bsky.social @alaingoriely.bsky.social &co describes #TauProtein dynamics in AD, showing stage-specific shifts in production & transport @plosbiology.org 🧪 plos.io/4kNA6vX

Babies have more of this Alzheimer’s-linked protein than dementia patients – study raises hope for future treatments
#Alzheimers #BrainDevelopment #MedicalResearch #Neuroscience #TauProtein #Tau #Dementia #Newborns #CognitiveHealth #Health
the-14.com/babies-have-...

Sleep Aid May Protect Brain from Alzheimer’s Damage - Neuroscience News A common sleep medication, lemborexant, may do more than promote rest—it appears to reduce harmful tau buildup and protect the brain from neurodegeneration in mouse models of Alzheimer’s disease.

New #research shows that a sleep aid may help reduce toxic #tau buildup linked to #Alzheimers - highlighting how quality sleep protects brain health! 😴

t.ly/RNZ7R

#BrainHealth #SleepMatters #TauProtein #rPeptide

Neurotoxic amyloid β-peptide and tau produce cytokine-like effects on PMCA in glioblastoma cell lines, enhancing its activity and isoforms expression

➡️ buff.ly/Qko5kA4

#Tauprotein #AlzheimersDisease #Glioblastoma

Neurotoxic amyloid β-peptide and tau produce cytokine-like effects on PMCA in glioblastoma cell lines, enhancing its activity and isoforms expression

👉 buff.ly/Qko5kA4

#Tauprotein #Glioblastoma #Astrocytes

Scientists Catch Alzheimer’s in the Act: Tau’s Secret Shift Uncovered What if Alzheimer’s doesn’t begin with the visible plaques we’ve long blamed? Scientists have now pinpointed a stealthier culprit: tiny clumps of the tau protein that form before the classic brain...

Scientists Catch Alzheimer’s in the Act: Tau’s Secret Shift Uncovered #Science #HealthandMedicine #Neurology #AlzheimersResearch #Neurodegeneration #TauProtein

Blood test detects early Alzheimer’s signs in people with memory concerns A new study confirms that plasma p-tau181 levels can identify subjective cognitive decline (SCD) as a distinct early stage of Alzheimer’s disease. This biomarker predicts cognitive decline and clinica...

Blood test detects early Alzheimer’s signs in people with memory concerns 🧠🧪🔍 www.news-medical.net/news/2025042... #Alzheimers #Biomarkers #Neurodegeneration #TauProtein #CognitiveHealth #Brain #Neuroscience #MemoryLoss #Dementia

What is tau protein?
Tau is like scaffolding for your brain cells. It keeps them stable and connected. But after #brain injury or in disease, tau can collapse and tangle. This blocks signals and disrupts the brain from the inside.
#TauProtein #Neuroscience #BrainHealth

Targeting Tau Protein: A New Avenue for Alzheimer’s Disease Treatment Recent research has identified specific modifications in the tau protein that contribute to Alzheimer's disease progression, offering promising targets for novel therapeutic interventions.

New research identifies specific tau protein modifications as early drivers of Alzheimer's disease, highlighting promising targets for novel treatments.

#AlzheimersResearch #TauProtein #Neurodegeneration

Brain health: Immune enzyme linked to toxic tau buildup in Alzheimer’s disease Researchers found that the immune enzyme TYK2 adds a tag to tau protein, causing toxic buildup in the brain. Blocking TYK2 reduced harmful tau and neuron damage in mice, offering a potential new target for Alzheimer’s treatment.

Researchers found that the immune enzyme TYK2 adds a tag to tau protein, causing toxic buildup in the brain. Blocking TYK2 reduced harmful tau and neuron damage in mice, offering a potential new target for Alzheimer’s treatment. #Alzheimers #BrainHealth #Neuroscience #TYK2 #TauProtein

Semaglutide enhances cognitive abilities and reduces Alzheimer’s pathology in mice and human brain models Researchers find that Semaglutide improves cognitive function and reduces amyloid and tau pathology in Alzheimer's disease models, while restoring oxytocin levels in both mice and human brain organoid...

Semaglutide enhances cognitive abilities and reduces Alzheimer’s pathology in mice and human brain models 🔬🧠🧪 www.news-medical.net/news/2024101... #Alzheimers #Neuroprotection #Semaglutide #Oxytocin #Brain #Neuroscience #AmyloidBeta #TauProtein

Amyloid-β and tau disrupt brain activity, driving early cognitive decline in Alzheimer’s risk Researchers discover how amyloid-β and tau pathologies interact to drive early neurophysiological changes and cognitive decline in older adults at risk of Alzheimer’s disease.

Amyloid-β and tau disrupt brain activity, driving early cognitive decline in Alzheimer’s risk 🧠🔬🧓 www.news-medical.net/news/2024092... #Alzheimers #Neuroscience #Brain #CognitiveDecline #AmyloidBeta #TauProtein #Dementia #Neurophysiology #PreventAD #Aging

Plasma pTau181 predicts Alzheimer’s progression in real-world memory clinic patients Researchers confirm plasma pTau181 is a strong predictor for Alzheimer's in patients with mild cognitive impairment, offering a less invasive diagnostic tool for early intervention.

Plasma pTau181 predicts Alzheimer’s progression in real-world memory clinic patients 🔬🧠📊 www.news-medical.net/news/2024092... #Alzheimers #Dementia #Plasma #Biomarkers #BrainHealth #Neurodegeneration #ADPathology #CognitiveImpairment #TauProtein